Navigation Links
State web site needs overhaul

Madison, Wis.It's a state website for the new century, complete with RSS news feeds, podcasts and automatic e-mail notifications of everything important to the average person, such as school closings, unexpected pollutant releases and changes in the status of known sex offenders.

It's easy on the eye, with words cast in muted shades of gray, blue and tan. It contains links helping ......

Full article >>>
'"/>

Source:wistechnology.com By Katherine Esposito 11/28/05


Page: 1 2 3 4

Related biology technology :

1. State to offer $850K in high-tech training grants
2. States need to be more "connectivity conscious"
3. State technology chief endorses IT audit recommendations
4. State provides $200K for Necedah ethanol plant
5. State video franchises vs. universal service: Grasping the total picture
6. State of Wisconsin dumps another tech project
7. States are the best laboratories for healthcare reform
8. State to fund two minority-owned tech businesses
9. State agencies propose venture capital center
10. Imago sells microscope to Iowa State
11. State pledges $50K to NovaScan, Platypus
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: State web site needs overhaul

Breaking Biology Technology:Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4